Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study
Positive news but a very small trial.....7 people. Not a game changer SP wise, but maybe down the road it will be. I fear though that it may be a very long road for all these trials. But I would think that all positive indications like this will help to keep the money flowing in.
